| Literature DB >> 34105693 |
Gennaro DE Marco1, Alessandro Lanza1, Corina M Cristache2, Estefani B Capcha3, Karen I Espinoza3, Rosario Rullo1, Rolando Vernal4, Emilio A Cafferata4,5, Fabrizio DI Francesco1.
Abstract
Third molar removal surgery usually comes accompanied by postoperative discomfort, which could be influenced by the surgical approach chosen. This scoping systematic review aimed at compiling the available evidence focused on the influence of flap design, including envelope flap (EF), triangular flap (TF), and modified triangular flap (MTF), on postoperative pain, swelling, and trismus, as primary outcome measures, and any result mentioning healing promotion or delay, as secondary outcome measure, after mandibular third molar extraction surgery. An electronic search, complemented by a manual search, of articles published from 1999 to 2020 was conducted in the Medline (PubMed), EMBASE and Web of Science databases including human randomized controlled trials, prospective, and retrospective studies with at least 15 patients. The risk of bias of the included studies was assessed either with the Cochrane's Risk of Bias tool or with the Newcastle-Ottawa scale. Every step of the review was performed independently and in duplicate. The initial electronic search recovered 2102 articles. After applying the inclusion criteria, 12 articles were included. For patient's perceived postoperative pain, TF and MTF frequently reported better results than EF. For swelling, the literature is divided, despite a trend favoring EF. For trismus, data showed that its occurrence is mostly associated with the duration of the surgery rather than with the chosen flap. For healing, the limited data is inconclusive. Finally, randomized studies showed a high risk of bias, whereas nonrandomized studies were mostly of good quality and low risk of bias. Although there was no clear consensus regarding the influence of different flap designs for third mandibular molar extraction on postoperative clinical morbidities; the surgeon's experience, estimated surgical difficulty, molar position and orientation, and surg ery duration should be considered when choosing among the different flap designs.Entities:
Mesh:
Year: 2021 PMID: 34105693 PMCID: PMC8232931 DOI: 10.1590/1678-7757-2020-0932
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Figure 1Envelope Flap (A), triangular flap (B) and modified Triangular Flap (C)
Figure 2PRISMA Flow chart for the data selection process
Descriptive summary of included studies
| Author | Study Design | Flap | Controls and Follow up | Pell and Gregory Classification |
|---|---|---|---|---|
| Alqahtani, et al10 | Retrospective | EF/MTF | 1, 3, 7, 8, 15 days and 3 weeks | NR |
| Mohajerani, et al11 | RCT | EF/MTF | 3, 7 days | I, II/C |
| Mobilio, et al12 | RCT | EF/TF | 2, 7 days | NR |
| Rabi, et al13 | Prospective | E/TF | 2, 3, 7 days | NR |
| Desai, et al14 | RCT | EF/TF | 15 days | NR |
| Koyuncu, et al15 | Prospective | EF/MTF | 1, 2, 7 days | NR |
| Baqain, et al16 | RCT | EF/TF | 2, 7, 14 days | NR |
| Erdogan, et al17 | Retrospective | EF/TF | 3, 7 days | I, II/A, B |
| Sandhu, et al18 | Retrospective | EF/MTF | 1, 3, 7, 14, 30 days | NR |
| Kirk, et al19 | Retrospective | EF/MTF | 1, 2, 7 days | NR |
| Dolanmaz, et al20 | Prospective | EF/MTF | 7 days | NR |
| Saima, et al21 | Prospective | EF/TF | 2, 7 days | NR |
RCT: randomized clinical trial; EF: envelope flap; TF: triangular flap; MTF: modified triangular flap; NR: not reported.
Reported differences between postoperative occurrence of pain, swelling, trismus and healing after using different access flap designs for third molar surgery in the included studies
| Author | Year | Patient Number | EF | TF | MTF | Pain | Swelling | Trismus | Healing |
|---|---|---|---|---|---|---|---|---|---|
| Alqahtani, et al10 | 2017 | 60 | 60 | 60 | = | ND | ND | ||
| Mohajerani, et al11 | 2018 | 31 | 28 | 28 | ND | ND | = | > MTF† | |
| Mobilio, et al12 | 2017 | 25 | 12 | 13 | = | = | = | ND | |
| Rabi, et al13 | 2017 | 50 | 25 | 25 | = | ND | ND | ||
| Desai, et al14 | 2014 | 30 | 15 | 15 | = | ND | = | ||
| Koyuncu, et al15 | 2013 | 80 | 40 | 40 | < MTF† | < MTF† | ND | ND | |
| Baqain, et al16 | 2012 | 19 | 19 | 19 | = | ND | |||
| Erdogan, et al17 | 2011 | 20 | 20 | 20 | < TF† | < EF† | = | ND | |
| Sandhu, et al18 | 2010 | 20 | 20 | 20 | = | = | |||
| Kirk, et al19 | 2007 | 32 | 32 | 32 | = | < MTF† | = | ND | |
| Dolanmaz, et al20 | 2013 | 30 | 30 | 30 | = | = | ND | ND | |
| Saima, et al21 | 2017 | 284 | 142 | 142 | = | = | = | ND |
EF: Envelope flap, MTF: modified triangular flap, TF: triangular flap. <: Less postoperative occurrence, >: More postoperatively occurrence; =: No statistical difference reported, †: Statistically not significant trend reported; *: Statistically significant difference reported. ND: Not determined.
Risk of bias and quality assessment of included nonrandomized studies using the Newcastle-Ottawa Scale
| Study | Selection | Comparability | Outcome | Total |
|---|---|---|---|---|
| max 4 **** | max 2 ** | max 3 *** | ||
| Alqahtani, et al10 | *** | * | *** | 7 |
| Rabi, et al13 | *** | * | ** | 6 |
| Kovuncu, et al15 | **** | * | *** | 8 |
| Erdogan, et al17 | **** | * | *** | 8 |
| Sandhu, et al18 | **** | ** | *** | 9 |
| Kirk, et al19 | **** | * | ** | 7 |
| Dolanmaz, et al20 | **** | ** | ** | 8 |
| Saima, et al21 | *** | * | * | 5 |
| NOS SCORE | ≥5 |
Risk of bias assessment of included RCTs using the Cochrane’s Risk of Bias tool
| Study | Sequence Generation | Allocation Concealment | Blinding Operators and Participants | Blinding of Results Surveys | Incomplete Outcome Data | Selecting Outcome Reporting | Other Bias |
|---|---|---|---|---|---|---|---|
| Mohajerani, et al11 | low | low | high | unclear | low | low | no |
| Mobilio, et al12 | low | unclear | high | low | low | low | no |
| Desai, et al14 | high | unclear | high | unclear | low | low | no |
| Baqain, et al16 | low | low | high | unclear | low | low | no |